The Ile164 β2-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to Gs

This publication has 22 references indexed in Scilit:

• Complex promoter and coding region β ₂ -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
  Proceedings of the National Academy of Sciences, 2000
• The Effect of Polymorphisms of the β₂-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma
  American Journal of Respiratory and Critical Care Medicine, 2000
• β agonists: What is the evidence that their use increases the risk of asthma morbidity and mortality?
  Journal of Allergy and Clinical Immunology, 1999
• A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic Receptor
  Journal of Biological Chemistry, 1999
• Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.
  Journal of Clinical Investigation, 1997
• Sustained Activation of a G Protein-coupled Receptor via “Anchored” Agonist Binding
  Journal of Biological Chemistry, 1996
• Salmeterol
  Medicinal Research Reviews, 1995
• Amino-Terminal Polymorphisms of the Human .beta.2-Adrenergic Receptor Impart Distinct Agonist-Promoted Regulatory Properties
  Biochemistry, 1994
• Salmeterol, a novel, long‐acting β₂‐adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo
  British Journal of Pharmacology, 1991
• An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation
  British Journal of Pharmacology, 1985